Table 7. Multivariate sensitivity analysis of key uncertain variables and incremental cost per birth attended, cost per death avoided, and cost per DALY averted of LUNESP package of neonatal interventions: 2011–2020 neonatal survival program (2011 US$).

	Incremental cost and cost-effectiveness ratios, point estimates			Incremental cost and cost-effectiveness ratios, Monte-Carlo simulation1
	Base case	Optimistic scenario	Conservative scenario	Base case	Optimistic scenario	Conservative scenario
Cost per death avoided 2	1866	591	3024	1960	610	3210
Minimum-maximum range				746–16683	293–3938	1106–45309
90% probability value				3706	1087	6922
Cost per DALY averted 2	74	24	120	76	24	128
Minimum-maximum range				27–664	12–157	44–1805
90% probability value				148	43	276
Cost per birth attended 2	29.1	9.2	35.4	29.2	9.2	35.5
Minimum-maximum range				18.6–76.3	7.6–16.9	20.2–232.6
90% probability value				43.3	11.5	63.5

¹20,000 trials were run for each simulation.

²Monte-carlo simulation values are the median value.